How many insider trades does FilingIQ track for VIR?

FilingIQ tracks 900 Form 4 insider transactions for VIR (Vir Biotechnology, Inc.), covering filings from Oct 16, 2019 onwards. 36 of those were filed in the last 90 days.

Are VIR insiders net buyers or net sellers?

Across the full Form 4 history for VIR, 12 transactions (1%) were open-market purchases and 427 (47%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does VIR insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is VIR in?

Vir Biotechnology, Inc. (VIR) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.05B.

VIR insider trading

Healthcare

Vir Biotechnology, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

900

Last 90 days

Buys / sells

1% / 47%

Market cap

$1.05B

About Vir Biotechnology, Inc.

Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors.The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). It has grant agreements with Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Company website: www.vir.bio

VIR insider activity at a glance

FilingIQ has scored 900 insider transactions for VIR since Oct 16, 2019. The most recent filing in our index is dated May 1, 2026.

Across the full history, 12 open-market purchases and 427 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on VIR insider trades is 54.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live VIR trades on FilingIQ Raw filings on SEC EDGAR

Latest VIR Form 4 filings

De Backer Marianne Chief Executive Officer

S Apr 3, 2025

De Backer Marianne Chief Executive Officer

S Apr 3, 2024

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding VIR

SB INVESTMENT ADVISERS (UK) LTD

$84.09M · 0.7% of AUM

Frequently asked

How many insider trades does FilingIQ track for VIR?: FilingIQ tracks 900 Form 4 insider transactions for VIR (Vir Biotechnology, Inc.), covering filings from Oct 16, 2019 onwards. 36 of those were filed in the last 90 days.
Are VIR insiders net buyers or net sellers?: Across the full Form 4 history for VIR, 12 transactions (1%) were open-market purchases and 427 (47%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does VIR insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is VIR in?: Vir Biotechnology, Inc. (VIR) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.05B.

Methodology & sources

Every VIR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.